Wockhardt is currently trading at Rs 697.00, up by 31.40 points or 4.72% from its previous closing of Rs 665.60 on the BSE.
The scrip opened at Rs 675.00 and has touched a high and low of Rs 715.50 and Rs 631.00 respectively. So far 928555 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 741.00 on 02-May-2012 and a 52 week low of Rs 251.25 on 06-Jan-2012.
Last one week high and low of the scrip stood at Rs 715.50 and Rs 631.00 respectively. The current market cap of the company is Rs 7380.90 crore.
The promoters holding in the company stood at 73.64% while Institutions and Non-Institutions held 7.31% and 18.82% respectively.
Wockhardt has reported net loss of Rs 68.64 crore for the quarter ended March 31, 2012, against net profit of Rs 32.25 crore for the corresponding period last fiscal. However, total income increased by 68.90% at Rs 722.93 crore during the quarter under review from Rs 428.03 crore in the year-ago period.
On the consolidated basis, the company has reported net loss of Rs 191.64 crore for the quarter ended March 31, 2012, against net profit of Rs 161.83 crore for the corresponding period last fiscal. However, total income increased by 32.63% at Rs 1248.13 crore during the quarter under review from Rs 941.03 crore in the year-ago period.
For the full year ended March 31, 2012, the company has reported net profit of Rs 184.00 crore for the year ended March 31, 2012, against net loss of Rs 132.07 crore for the corresponding period last fiscal. Total income increased by 45.63% at Rs 2580.52 crore during the year under review from Rs 1772.01 crore in the year-ago period.
On the consolidated basis, the company has posted a rise of 278.60% in its net profit at Rs 342.71 crore for the year ended March 31, 2012 as compared to Rs 90.52 crore for the same period in the previous year. Total income has increased by 23.08% at Rs 4637.26 crore for year under review as compared to Rs 3767.14 crore for the period ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |